Devesh Pandya

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    BMS
    Topic:
    speaker
    Date added:
    07/27/2024
    Date updated:
    07/27/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Gilead
    Topic:
    speaker
    Date added:
    07/27/2024
    Date updated:
    07/27/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    AstraZeneca
    Topic:
    speaker
    Date added:
    07/27/2024
    Date updated:
    07/27/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Jazz Pharmaceuticals
    Topic:
    speaker
    Date added:
    07/27/2024
    Date updated:
    07/27/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    GSK
    Topic:
    speaker
    Date added:
    07/27/2024
    Date updated:
    07/27/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    EMD Serono
    Topic:
    speaker
    Date added:
    07/27/2024
    Date updated:
    07/27/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    SeaGen
    Topic:
    speaker
    Date added:
    07/27/2024
    Date updated:
    07/27/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Myriad
    Topic:
    speaker
    Date added:
    07/27/2024
    Date updated:
    07/27/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Guardant Health
    Topic:
    speaker
    Date added:
    07/27/2024
    Date updated:
    07/27/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Janssen
    Topic:
    speaker
    Date added:
    07/27/2024
    Date updated:
    07/27/2024

Pages

Return to Best of Hematology and Breast Cancer 2025, Houston